Exploration for Traditional Antimalarial Medicinal Plants in Central Africa

中部非洲传统抗疟药用植物的探索

• 批准号: 14406029
• 负责人: MURAKAMI Nobutoshi
• 金额: $ 6.02万
• 依托单位: Osaka University
• 依托单位国家: 日本
• 项目类别: Grant-in-Aid for Scientific Research (B)
• 财政年份: 2002
• 资助国家: 日本
• 起止时间: 2002 至 2003
• 项目状态: 已结题
• 来源: https://kaken.nii.ac.jp/en/grant/KAKENHI-PROJECT-14406029/
• 关键词: malaria; medicinal plants; central Africa; traditional antimalarials; flavonol monoglycoside; Democratic Republic of Congo; iridoid; flavonoid-C-glycoside; 中央アフリカ; コンゴ; 抗マラリア; 薬用植物; 伝承薬; フラボノイド配糖体; 選択毒性; 成分探索

In this project, our group visited the Democratic Republic of Congo in order to search and collect medicinal plants used for malaria therapy traditionally. With the assistance of Dr. Kubata, a Professor of Kinshasa University and local healers who prescribe medicinal plants to local people we could collect 18 kinds of antimalarial medicinal plants. In the first instance, we evaluated for in vitro growth inhibitory activity on malaria parasites. As a result of our evaluation, 15 kinds of medicinal plants were shown to inhibit proliferation of Plasmodium falciparum potently. Next, We assessed in vivo antimalarial efficacy by use of P. berghei infected mice. In consequence, the three medicinal plants, Euphorbia hirta, Hymenocardia acida, Morinda morindoides, were revealed to exhibit attractive in vivo potency without showing any cytotoxicity. Furthermore, bioassay-guided separation of the MeOH extracts of the three plants resulted in the isolation of flavonol monoglycosides, flavonoid-C-glycosides, and phenyl propanoid conjugated iridoids as responsible active principles. It should be noteworthy that the three active principles are fairly different from known antimalarial drugs in terms of their chemical structures. In addition, all of the three active principles showed antimalarial activity against a drug resistance strain.

在这个项目中，我们的小组访问了刚果民主共和国，以搜查和收集传统上用于疟疾疗法的药用植物。在金沙萨大学教授库巴塔（Kubata）博士和当地治疗师的协助下，他们为当地人民开了药用植物，我们可以收集18种抗疟药植物。首先，我们评估了对疟疾寄生虫的体外生长抑制活性。由于我们的评估，15种药用植物被证明可有效抑制恶性疟原虫的增殖。接下来，我们通过使用贝尔格（P. berghei）感染的小鼠评估了体内抗疟疾功效。结果，据揭示了三种药用植物，欣快的hirta，hymenarcardia酸，莫林达·莫林多德斯（Morinda Morindoides），在没有任何细胞毒性的情况下表现出具有吸引力的体内效力。此外，三种植物的MEOH提取物的生物测定引导分离导致黄酮醇一糖苷，类黄酮-C-糖苷和苯基抗抗抗性的共轭的虹吸的虹膜轭为负责的活性原理。应该值得注意的是，从化学结构方面，这三个主动原理与已知的抗疟药有很大不同。此外，所有三种主动原理均显示出针对耐药性菌株的抗疟疾活性。

项目成果

N.Murakami et al.: "New Rev-Transport Inhibitor with Anti-HIV Activity from Valerianae Radix"Bioorg. &Med. Chem. Lett.. 12(20). 2807-2810 (2002)

N.Murakami 等人：“缬草中具有抗 HIV 活性的新型 Rev 转运抑制剂”Bioorg。

N.Murakami et al.: "New Analogue of Arenastatin A, a Potent Cytotoxic Spongean Depsipeptide, with Anti-tumor Activity"Bioorg.Med.Chem.Lett.. 14(in press). (2004)

N.Murakami 等人：“Arenastatin A 的新类似物，一种有效的细胞毒性海绵缩酚肽，具有抗肿瘤活性”Bioorg.Med.Chem.Lett.. 14（印刷中）。

N.Murakami et al.: "Facilely Accessible Multidrug Resistance Modulator Derived from Sucrose"Bioorg. &Med. Chem. Lett.. 12(22). 2807-2810 (2002)

N.Murakami 等人：“源自蔗糖的易于获得的多药耐药性调节剂”Bioorg。

N.Murakami et al.: "Exploration for anti-cancer leads through synthetic approach utilizing biologically active natural products as seed principles"Natural Medicines. 56(3). 73-77 (2002)

N.Murakami 等人：“通过利用生物活性天然产物作为种子原理的合成方法来探索抗癌”天然药物。

N.Murakami et al.: "Synthesis of a Bioprobe for Elucidation of Target Molecule of Spongean Anti-malarial Peroxides."Bioorg.Med.Chem.Lett.. 14(in press). (2004)

N.Murakami 等人：“用于阐明海绵抗疟疾过氧化物目标分子的生物探针的合成”。Bioorg.Med.Chem.Lett.. 14（印刷中）。